Food and Drug Administration

Speedy drug approvals are risky, but drug companies have another idea that's just terrible

Speedy drug approvals are risky, but drug companies have another idea that's just terrible

At a recent meeting with pharmaceutical-industry bigwigs, President Trump declared that “we’re going to be cutting regulations at a level that nobody’s ever seen before.” He also said that “we’re going to have tremendous protection for the people.”

It’s hard to see how he can do both.

As with Trump’s proposed elimination of consumer safeguards, environmental-protection measures and financial reforms, the reality is that if his administration proceeds with a wholesale deregulation of the drug industry, the public will be largely undefended against the aggressive and potentially dangerous predations of multibillion-dollar conglomerates.

“We need regulations to make sure...

49°